当前位置: 首页 >> 检索结果
6784. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
作者: Tara Gomes.;Tonya J Campbell.;Sophie A Kitchen.;Ria Garg.;Nikki Bozinoff.;Siyu Men.;Mina Tadrous.;Charlotte Munro.;Tony Antoniou.;Dan Werb.;Jennifer Wyman.
来源: JAMA. 2022年327卷9期846-855页
During the COVID-19 pandemic, modified guidance for opioid agonist therapy (OAT) allowed prescribers to increase the number of take-home doses to promote treatment retention. Whether this was associated with an increased risk of overdose is unclear.
6785. Association of Acute Respiratory Failure in Early Childhood With Long-term Neurocognitive Outcomes.
作者: R Scott Watson.;Sue R Beers.;Lisa A Asaro.;Cheryl Burns.;Min Jung Koh.;Mallory A Perry.;Derek C Angus.;David Wypij.;Martha A Q Curley.; .
来源: JAMA. 2022年327卷9期836-845页
Approximately 23 700 US children undergo invasive mechanical ventilation for acute respiratory failure annually, with unknown long-term effects on neurocognitive function.
6788. Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review.
作者: John A Belperio.;Faisal Shaikh.;Fereidoun G Abtin.;Michael C Fishbein.;S Samuel Weigt.;Rajan Saggar.;Joseph P Lynch.
来源: JAMA. 2022年327卷9期856-867页
Sarcoidosis is an inflammatory granulomatous disease of unknown cause that affects an estimated 2 to 160 people per 100 000 worldwide and can involve virtually any organ. Approximately 10% to 30% of patients with sarcoidosis develop progressive pulmonary disease.
|